The interview is very promising, in my opinion. Management expects to have one or two FDA-approved products by the end of 2010 and these products have the potential to be very successful because they are needle-free (transdermal) alternatives to today's products.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.